Nurse Practitioner, Family · Minot, ND
NPI
1205986742
Since 2007
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1201 11th Ave SW
Minot, ND, 58701
Phone (701) 858-6700
Groups this clinician bills Medicare through
Medicare paid, 2024
$21K
735 services
Medicare patients, 2024
78
Average age 73
Drug cost, 2024
$176K
2,054 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Terrilyn Braasch was code 36415 (venipuncture blood collection), 106 times for 59 patients. In total Terrilyn Braasch billed 735 services in 65 codes, and Medicare paid $21K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-09-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 106 | 59 | $8.65 | $917 |
| 99215 Office E&M - Established | Office | 88 | 47 | $97.03 | $8,539 |
| 80053 Clinical Chemistry | Office | 65 | 49 | $10.35 | $673 |
| 99214 Office E&M - Established | Office | 48 | 29 | $69.64 | $3,343 |
| 85025 Blood Count | Office | 48 | 41 | $7.61 | $365 |
| 84443 Clinical Chemistry | Office | 47 | 39 | $16.46 | $774 |
| 83036 Blood Count | Office | 44 | 31 | $9.52 | $419 |
| 80061 Clinical Chemistry | Office | 44 | 39 | $13.12 | $577 |
| 80048 Clinical Chemistry | Office | 23 | 18 | $8.29 | $191 |
| 90662 Vaccine Product | Office | 15 | 14 | $72.85 | $1,093 |
| 82607 Clinical Chemistry | Office | 13 | 13 | $14.78 | $192 |
| G0008 Administration of influenza virus vaccine | Office | 13 | 13 | $31.28 | $407 |
| 82570 Clinical Chemistry | Office | 12 | 11 | $5.08 | $60.96 |
| 82043 Clinical Chemistry | Office | 12 | 11 | $5.66 | $67.92 |
By year: 2022 $26K for 900 services; 2023 $27K for 914 services; 2024 $21K for 735 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 106 | 59 | $8.65 | $917 |
| 80053 Clinical Chemistry | 65 | 49 | $10.35 | $673 |
| 85025 Blood Count | 48 | 41 | $7.61 | $365 |
| 84443 Clinical Chemistry | 47 | 39 | $16.46 | $774 |
| 83036 Blood Count | 44 | 31 | $9.52 | $419 |
| 80061 Clinical Chemistry | 44 | 39 | $13.12 | $577 |
| 80048 Clinical Chemistry | 23 | 18 | $8.29 | $191 |
| 82607 Clinical Chemistry | 13 | 13 | $14.78 | $192 |
| 82570 Clinical Chemistry | 12 | 11 | $5.08 | $60.96 |
| 82043 Clinical Chemistry | 12 | 11 | $5.66 | $67.92 |
Medicare prescription drug claims, 2024
In 2024, the drug Terrilyn Braasch prescribed most often to Medicare patients was Levothyroxine Sodium, with 97 prescriptions and refills. In total Terrilyn Braasch wrote 2,054 Medicare prescriptions that cost $176K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 97 | 202 | 20 | $1,466 |
| Metoprolol Succinate Generic | 91 | 241 | 23 | $1,823 |
| Omeprazole Generic | 88 | 203 | 22 | $1,281 |
| Losartan Potassium Generic | 84 | 197 | 21 | $855 |
| Rosuvastatin Calcium Generic | 77 | 193 | 18 | $599 |
| Metformin Hcl Generic | 75 | 177 | 15 | $589 |
| Pantoprazole Sodium Generic | 73 | 126 | 15 | $955 |
| Lisinopril Generic | 72 | 176 | 18 | $772 |
| Atorvastatin Calcium Generic | 65 | 151 | 16 | $467 |
| Gabapentin Generic | 56 | 106 | 13 | $651 |
| Simvastatin Generic | 54 | 126 | 12 | $263 |
| Meloxicam Generic | 43 | 55 | Under 11 | $403 |
| Furosemide Generic | 43 | 93 | 11 | $321 |
| Amlodipine Besylate Generic | 38 | 112 | 12 | $308 |
| Duloxetine Hcl Generic | 37 | 61 | Under 11 | $841 |
Brand drugs: 259 claims; generic drugs: 1,779 claims; opioid claims: 30.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Terrilyn Braasch were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.